Keywords: novavax, esprit, pharma, develop, testosterone-based, sdd, patch

Novavax and Esprit Pharma to develop a testosterone-based SDD patch

Article | 29 May 2006

Print This

USA-based drugmaker Novavax says that it has signed a contract with fellow US company Esprit Pharma to develop a testosterone-based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in